Research Notice: Research cited on this page is independent, peer-reviewed scientific work. BGREEN and Turtlegym products are wellness and lifestyle equipment — they are not medical devices and are not intended to diagnose, treat, cure, or prevent any medical condition. Findings from independent research do not constitute claims about Vibrahealth products. Persons with health conditions should consult a qualified healthcare professional before use.
Research Summary
Peer-reviewed studies have found that WBV was associated with improvements in glycaemic markers — including HbA1c and fasting blood glucose — and insulin sensitivity in participants with type 2 diabetes. Proposed mechanisms include increased glucose transporter (GLUT4) activity in skeletal muscle and improved peripheral blood flow triggered by vibration. WBV is not a medical treatment for diabetes; these findings from independent research suggest it may complement, but not replace, standard lifestyle and pharmacological management.
Research at a Glance
| Study | Year | Evidence Type | Population | Key Finding (as reported) |
|---|---|---|---|---|
| Binesh et al. | 2024 | Systematic Review + Network Meta-Analysis | Adults with type-2 diabetes | WBVV was associated with reductions in HbA1c and improvements in glycemic control parameters in type-2 diabetes patients; PROSPERO registered |
Why This Topic Matters
Singapore has one of the highest rates of type-2 diabetes in the developed world. According to the Ministry of Health Singapore, approximately 1 in 3 Singaporeans aged 65 and above lives with the condition, and among those aged 60–69, the prevalence exceeds 30%. The burden on individuals, families, and the healthcare system is significant — diabetes is a leading cause of kidney failure, blindness, lower limb amputation, and cardiovascular disease in Singapore.
Sustained physical activity is a cornerstone of diabetes management — it improves insulin sensitivity, supports weight management, and reduces cardiovascular risk. However, many older adults with diabetes face significant barriers to conventional exercise: joint pain, peripheral neuropathy, balance impairment, fatigue, and cardiovascular complications all reduce exercise capacity and increase injury risk. Conventional aerobic exercise programmes, while effective, can be difficult to maintain in these populations.
Researchers have examined Whole Body Vertical Vibration (WBVV) as a passive exercise modality that could potentially influence glycemic parameters — offering an exercise-like stimulus without the barriers associated with voluntary physical activity.
Relevant for: Endocrinologists and physicians managing diabetes · Healthcare professionals working with diabetic older adults · Physiotherapists evaluating exercise options for diabetic patients · Corporate wellness managers · Individuals with type-2 diabetes exploring exercise options
Research Overview
The primary study for this topic area is the 2024 Binesh et al. systematic review and network meta-analysis published in Scientific Reports (Nature Portfolio). This is Level 1a evidence — the highest tier of the clinical evidence hierarchy — because it statistically synthesises data from multiple randomised controlled trials rather than relying on a single trial.
Types of studies: network meta-analyses (synthesising multiple RCTs via indirect comparison); individual RCTs examining WBV against control or active comparators; the network meta-analysis approach allows comparison of WBV against multiple other interventions simultaneously via shared comparators.
What researchers have examined: the primary glycemic outcome is HbA1c (glycated haemoglobin — a marker of average blood sugar control over 2–3 months); secondary outcomes include fasting blood glucose, postprandial glucose, lipid profiles, and body composition. The PROSPERO registration (CRD42023438514) indicates the review was pre-registered — an important quality marker that reduces the risk of selective reporting.
Population: adults with type-2 diabetes mellitus, including both younger and older adults with the condition.
Key Published Studies
Binesh et al. (2024)
What they examined: Researchers conducted a systematic review with network meta-analysis of the effects of exercise modalities on glycemic control in patients with type-2 diabetes. The study was pre-registered on PROSPERO (registration number CRD42023438514) — an important quality indicator that confirms the review’s scope and analysis plan were specified before data collection began. The review synthesised evidence from multiple RCTs using the PEDro quality scale to assess the methodological quality of included trials.
What researchers reported: WBV was associated with reductions in HbA1c and improvements in glycemic control parameters in type-2 diabetes patients. The network meta-analysis methodology allowed researchers to compare the relative effects of WBV against other exercise modalities and control conditions across the included trials.
Why this matters: This is the highest tier of clinical evidence for this topic — Level 1a (systematic review with meta-analysis). The PROSPERO pre-registration confirms the review was not selectively reported. The PEDro quality scale provides a transparent assessment of trial quality in the included studies.
Methodology Notes
The PROSPERO registration (CRD42023438514) is an important quality marker. PROSPERO is an international database of prospectively registered systematic reviews. Registration before conducting the review reduces the risk of selective reporting and allows readers to verify that the published review followed its pre-specified plan.
The PEDro quality scale was used to assess the methodological quality of included trials. PEDro scores provide a transparent assessment of trial quality, with scores above 6 generally indicating good methodological quality. Readers should note that even high-quality RCTs included in a meta-analysis are bounded by the quality of the underlying trials.
Network meta-analysis methodology allows indirect comparison between interventions that have not been directly compared in head-to-head trials. This is particularly valuable in exercise research, where it is impractical to directly compare every exercise modality in a single trial. The network approach increases the analytical power of the available evidence.
HbA1c as an outcome: HbA1c reflects average blood glucose control over approximately 2–3 months and is the gold-standard clinical measure of long-term glycemic management. A reduction in HbA1c is clinically meaningful — every 1% reduction is associated with a approximately 37% reduction in microvascular complications and a 21% reduction in any diabetes-related endpoint.
Frequently Asked Questions
What does research say about WBV and type-2 diabetes?
The primary evidence is the 2024 Binesh et al. systematic review and network meta-analysis published in Scientific Reports — Level 1a evidence. Researchers reported that WBV was associated with reductions in HbA1c and improvements in glycemic control parameters in type-2 diabetes patients. The PROSPERO pre-registration confirms this was a pre-planned review with a transparent methodology.
Has WBV been shown to reduce HbA1c in diabetes patients?
The 2024 Binesh et al. network meta-analysis reported that WBV was associated with reductions in HbA1c in type-2 diabetes patients. HbA1c is the gold-standard clinical measure of long-term glycemic management. The network meta-analysis approach synthesised data from multiple RCTs, providing a more robust estimate than any single trial alone. The specific magnitude of HbA1c reduction would depend on the individual studies included and the protocol used.
What type of study is the Binesh et al. 2024 meta-analysis?
It is a systematic review with network meta-analysis (Level 1a evidence). It was pre-registered on PROSPERO (CRD42023438514), confirming the review scope and analysis plan were specified before data collection. The methodological quality of included RCTs was assessed using the PEDro scale. A network meta-analysis allows indirect comparison of WBV against multiple other exercise modalities — an efficient approach to comparing interventions that have not been directly compared in head-to-head trials.
Is WBV a substitute for exercise in diabetes management?
No. No study claims that WBV substitutes for conventional exercise in diabetes management. The research suggests that WBV may be associated with improvements in glycemic parameters — a distinct claim from saying WBV replaces exercise. Physical activity remains a cornerstone of diabetes management. WBV may be of interest as a passive modality for populations where conventional exercise is impractical or unsafe — but individuals with diabetes should follow their healthcare team’s exercise recommendations.
Why might WBV be of interest for Singaporeans with diabetes?
Singapore has one of the highest diabetes prevalence rates in the developed world — approximately 1 in 3 Singaporeans aged 65 and above has type-2 diabetes. Many older diabetics face barriers to conventional exercise including joint pain, neuropathy, balance impairment, and fatigue. A passive exercise modality that can deliver a mechanical stimulus without requiring voluntary physical effort may be of particular interest for this population. The 2024 meta-analysis provides Level 1a evidence that WBV is associated with glycemic improvements — making it a topic of interest for healthcare professionals managing Singapore’s diabetes burden.
Related Topics
- WBV and Cardiovascular Health Research
- WBV and Nursing Home Elderly Research
- WBV and Sarcopenia Research
At Vibrahealth
BGREEN WBVV products — the uChair, uSofa, and uFit vibration plates — are wellness equipment designed to deliver vertical vibration exercise. They are not medical devices and are not intended to treat type-2 diabetes or any medical condition. Healthcare professionals are welcome to book a complimentary demonstration at our Wellness Lounge at The Adelphi, Singapore.
For enquiries about corporate wellness programmes, visit our Corporate Wellness page.
Sources
- Binesh et al. (2024). Effect of exercise modalities on glycemic control in patients with type-2 diabetes: a systematic review and network meta-analysis. Scientific Reports. PROSPERO registration: CRD42023438514. https://doi.org/10.1038/s41598-024-63316-0
Research Notice: Research cited on this page is independent, peer-reviewed scientific work. BGREEN and Turtlegym products are wellness and lifestyle equipment — they are not medical devices and are not intended to diagnose, treat, cure, or prevent any medical condition. Findings from independent research do not constitute claims about Vibrahealth products. Persons with health conditions should consult a qualified healthcare professional before use.